Related references
Note: Only part of the references are listed.A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma
Fatma E. El-Khouly et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR
Philipp Sievers et al.
NEURO-ONCOLOGY (2021)
Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition
Gourish Monday et al.
ACTA NEUROPATHOLOGICA (2020)
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
Antoine Forget et al.
CANCER CELL (2018)
Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction
Myeongjin Jeon et al.
ONCOTARGET (2017)
ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology
Nico Jacobi et al.
CANCERS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra
Juliann Chmielecki et al.
CANCER RESEARCH (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Implementation of mechanism of action biology-driven early drug development for children with cancer
Andrew D. J. Pearson et al.
EUROPEAN JOURNAL OF CANCER (2016)
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study
Barbara C. Worst et al.
EUROPEAN JOURNAL OF CANCER (2016)
Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer
Quanxia Lv et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape
Amar Gajjar et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)
Mariko DeWire et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer
Ryan A. Hutchinson et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Childhood and adolescent cancer statistics, 2014
Elizabeth Ward et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Garbage in, garbage out: A critical evaluation of strategies used for validation of immunohistochemical biomarkers
Gillian O'Hurley et al.
MOLECULAR ONCOLOGY (2014)
A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer
Helmout Modjtahedi et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
The ErbB/HER family of protein-tyrosine kinases and cancer
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2014)
Reproducibility of Immunohistochemical Scoring for Epidermal Growth Factor Receptor Expression in Non-Small Cell Lung Cancer Round Robin Test
Josef Rueschoff et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters
Stephen W. Gilheeney et al.
FUTURE ONCOLOGY (2012)
Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker
Flavio Solca et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Expression and significance of HER family receptors in neuroblastic tumors
Ewa Izycka-Swieszewska et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Feedback regulation of EGFR signalling: decision making by early and delayed loops
Roi Avraham et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors
Birgit Geoerger et al.
NEURO-ONCOLOGY (2011)
Signaling of ERBB Receptor Tyrosine Kinases Promotes Neuroblastoma Growth In Vitro and In Vivo
Kristen N. Richards et al.
CANCER (2010)
A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
Brian Thiessen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor α and Poly (ADP-ribose) Polymerase As Potential Therapeutic Targets
Maryam Zarghooni et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The role of HER2 in cancer therapy and targeted drug delivery
Wanyi Tai et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Prognostic significance of HER2 expression in neuroblastic tumors
Ewa Izycka-Swieszewska et al.
MODERN PATHOLOGY (2010)
EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines
Dorine A. Bax et al.
CLINICAL CANCER RESEARCH (2009)
Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2β as biomarkers for rhabdomyosarcoma diagnostics
Beate Grass et al.
HISTOPATHOLOGY (2009)
Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer
F. R. Hirsch et al.
ONCOGENE (2009)
Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study
Regina I. Jakacki et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Direct multiplexed measurement of gene expression with color-coded probe pairs
Gary K. Geiss et al.
NATURE BIOTECHNOLOGY (2008)
Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective
Judith M. de Bont et al.
NEURO-ONCOLOGY (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma
Ramapriya Ganti et al.
MODERN PATHOLOGY (2006)
EGF-ERBB signalling: towards the systems level
Ami Citri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma
F Mendrzyk et al.
CLINICAL CANCER RESEARCH (2006)
Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry
M Wachtel et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay
Marileila Varella-Garcia
DIAGNOSTIC PATHOLOGY (2006)
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: A children's oncology group study
NC Daw et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
ERBB2 in pediatric cancer: Innocent until proven guilty
RJ Gilbertson
ONCOLOGIST (2005)
Epidermal growth factor receptor in non-small-cell lung carcinomas:: Correlation between gene copy number and protein expression and impact on prognosis
FR Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors
TPJ Garrett et al.
MOLECULAR CELL (2003)
Autocrine loops with positive feedback enable context-dependent cell signaling
SY Shvartsman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Analysis of the transcriptional program induced by Raf in epithelial cells
A Schulze et al.
GENES & DEVELOPMENT (2001)
Share Paper
